CD47 and neoplasm: Encouragingly, when an anti‐CD47 antibody was added, the effects of the CAR‐MΦ‐mediated in vivo tumor phagocytosis and induced adaptive immunity were further boosted, leading to robust tumor control and prolonging the survival time of all animals to >120 days.